Patient-Centered Acupuncture for Pain (PCAP)

Cancer Survivors Clinical Trial

Official title:

Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02152020
• Other study ID #: UPCC 01914
• Status: Completed
• Phase: N/A
• First received: May 29, 2014
• Last updated: January 13, 2015
• Start date: May 2014
• Est. completion date: January 2015

Study information

• Verified date: January 2015
• Source: Abramson Cancer Center of the University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Women or men age 18 years or older

• Primary diagnosis of cancer with history of stage I, II, or III cancer

• Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)

• Have a Karnofsky score of 60 or greater

• Can understand written English

• Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week

• Have been taking pain medications daily

• Have had at least 15 days with pain in the preceding 30 days.

Exclusion Criteria:

• Women or men with metastatic (stage IV) cancer

• Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks

• Planned surgical procedures in the next 12 weeks

• Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization

• Women who are pregnant or breastfeeding

• Unwillingness to adhere to study related procedures.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Cancer Survivors

Intervention

Behavioral:
• Survey

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Adverse Events		12 weeks	No